20 May 2013
Keywords: US, Drug pricing, GAO, House of Representatives
Article | 19 November 2009
Following recent allegations in the New York Times, and rebuttals by the US research-based pharmaceutical industry (The Pharma Letter November 18), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 November 2009
17 May 2013
© 2013 thepharmaletter.com